153 related articles for article (PubMed ID: 33868646)
1. Cloning of human
Vats N; Sanal MG; Venugopal SK; Taneja P; Sarin SK
F1000Res; 2020; 9():1498. PubMed ID: 33868646
[No Abstract] [Full Text] [Related]
2. Zebrafish abcb11b mutant reveals strategies to restore bile excretion impaired by bile salt export pump deficiency.
Ellis JL; Bove KE; Schuetz EG; Leino D; Valencia CA; Schuetz JD; Miethke A; Yin C
Hepatology; 2018 Apr; 67(4):1531-1545. PubMed ID: 29091294
[TBL] [Abstract][Full Text] [Related]
3. Targeting the AAVS1 Site by CRISPR/Cas9 with an Inducible Transgene Cassette for the Neuronal Differentiation of Human Pluripotent Stem Cells.
Gu J; Rollo B; Sumer H; Cromer B
Methods Mol Biol; 2022; 2495():99-114. PubMed ID: 35696030
[TBL] [Abstract][Full Text] [Related]
4. Gene Editing in Human Induced Pluripotent Stem Cells Using Doxycycline-Inducible CRISPR-Cas9 System.
Thamodaran V; Rani S; Velayudhan SR
Methods Mol Biol; 2022; 2454():755-773. PubMed ID: 33830454
[TBL] [Abstract][Full Text] [Related]
5. Identification
Yum SY; Choi W; Kim S; Jang G; Koo O
Anim Biotechnol; 2023 Dec; 34(9):4730-4735. PubMed ID: 36905152
[TBL] [Abstract][Full Text] [Related]
6. Quantification of transgene expression in GSH AAVS1 with a novel CRISPR/Cas9-based approach reveals high transcriptional variation.
Inderbitzin A; Loosli T; Kouyos RD; Metzner KJ
Mol Ther Methods Clin Dev; 2022 Sep; 26():107-118. PubMed ID: 35795775
[TBL] [Abstract][Full Text] [Related]
7. Differential Transgene Silencing of Myeloid-Specific Promoters in the
Klatt D; Cheng E; Hoffmann D; Santilli G; Thrasher AJ; Brendel C; Schambach A
Hum Gene Ther; 2020 Feb; 31(3-4):199-210. PubMed ID: 31773990
[TBL] [Abstract][Full Text] [Related]
8. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
[TBL] [Abstract][Full Text] [Related]
9. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.
Stindt J; Ellinger P; Weissenberger K; Dröge C; Herebian D; Mayatepek E; Homey B; Braun S; Schulte am Esch J; Horacek M; Canbay A; Schmitt L; Häussinger D; Kubitz R
Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865
[TBL] [Abstract][Full Text] [Related]
10. Determining On-Target, Off-Target, and Copy Number Status of Transgenic Events After CRISPR/Cas9 Targeted AAVS1 Safe-Harbor Modification of iPSCs Using Double-Control Quantitative Copy Number PCR.
Schjeide BM; Püschel GP
Curr Protoc; 2023 Jan; 3(1):e635. PubMed ID: 36598341
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of Genomic Safe Harbors as Target Sites for Stable Expression of the Heterologous Gene in HEK293 Cells.
Shin S; Kim SH; Shin SW; Grav LM; Pedersen LE; Lee JS; Lee GM
ACS Synth Biol; 2020 Jun; 9(6):1263-1269. PubMed ID: 32470292
[TBL] [Abstract][Full Text] [Related]
12. ABCB11 deficiency presenting as transient neonatal cholestasis: Correlation with genotypes and BSEP expression.
Li LT; Li ZD; Yang Y; Lu Y; Xie XB; Chen L; Feng JY; Knisely AS; Wang JS
Liver Int; 2020 Nov; 40(11):2788-2796. PubMed ID: 32808743
[TBL] [Abstract][Full Text] [Related]
13. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.
Caron J; Pène V; Tolosa L; Villaret M; Luce E; Fourrier A; Heslan JM; Saheb S; Bruckert E; Gómez-Lechón MJ; Nguyen TH; Rosenberg AR; Weber A; Dubart-Kupperschmitt A
Stem Cell Res Ther; 2019 Jul; 10(1):221. PubMed ID: 31358055
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-Based Safe-Harbor Gene Editing in Rhesus iPSCs.
Yada RC; Ostrominski JW; Tunc I; Hong SG; Zou J; Dunbar CE
Curr Protoc Stem Cell Biol; 2017 Nov; 43():5A.11.1-5A.11.14. PubMed ID: 29140568
[TBL] [Abstract][Full Text] [Related]
15. Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content Screening.
Vojnits K; Nakanishi M; Porras D; Kim Y; Feng Z; Golubeva D; Bhatia M
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458632
[TBL] [Abstract][Full Text] [Related]
16. Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11).
Lang T; Haberl M; Jung D; Drescher A; Schlagenhaufer R; Keil A; Mornhinweg E; Stieger B; Kullak-Ublick GA; Kerb R
Drug Metab Dispos; 2006 Sep; 34(9):1582-99. PubMed ID: 16763017
[TBL] [Abstract][Full Text] [Related]
17. A study of exons 14, 15, and 24 of the ABCB11 gene in Egyptian children with normal GGT cholestasis.
Selim N; Omair H; El-Karaksy H; Fathy M; Mahmoud E; Baroudy S; Fathy M; Yassin N
Arab J Gastroenterol; 2022 Feb; 23(1):15-19. PubMed ID: 35153175
[TBL] [Abstract][Full Text] [Related]
18. Rapid Disruption of Genes Specifically in Livers of Mice Using Multiplex CRISPR/Cas9 Editing.
Pankowicz FP; Barzi M; Kim KH; Legras X; Martins CS; Wooton-Kee CR; Lagor WR; Marini JC; Elsea SH; Bissig-Choisat B; Moore DD; Bissig KD
Gastroenterology; 2018 Dec; 155(6):1967-1970.e6. PubMed ID: 30170115
[TBL] [Abstract][Full Text] [Related]
19. Efficient viral delivery of Cas9 into human safe harbor.
Hayashi H; Kubo Y; Izumida M; Matsuyama T
Sci Rep; 2020 Dec; 10(1):21474. PubMed ID: 33293588
[TBL] [Abstract][Full Text] [Related]
20. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
